Results 71 to 80 of about 4,937 (255)

The study of antibodies level to glial tumours antigens in blood of neurooncological patients

Ukrainian Neurosurgical Journal, 2009
The level of antibodies to tumor tissue at patients with brain tumors was studied using enzyme-linked immunosorbent assay with tumor cells.Antibodies to antigens of glial tumors were found in the blood of neurooncological patients. The highest
N. I. Lisyany, L. N. Belska, V. D. Rozumenko, A. I. Potapova   +3 more
doaj   +1 more source

Clinical and Molecular Features of BAP1‐Mutated Meningiomas: Case Series

Molecular Carcinogenesis, EarlyView.
ABSTRACT BRCA1‐associated protein 1 (BAP1)‐deficient meningiomas represent a clinically and molecularly distinct subgroup with variable histology and aggressive behavior that may not be fully captured by current grading criteria. The clinical spectrum of BAP1 alterations in meningiomas, including both somatic and germline contexts, remains incompletely
Ivan Pradilla, Rasha Alfattal, Susan L. McGovern, Shaan M. Raza, Franco DeMonte, Leomar Y. Ballester, Chirag B. Patel, Carlos Kamiya‐Matsuoka   +7 more
wiley   +1 more source

Pleomorphic xanthoastrocytoma with anaplastic features

Chinese Journal of Contemporary Neurology and Neurosurgery, 2015
Objective  To explore the clinical pathological characteristics, immunophenotyping, diagnosis and differential diagnosis and prognosis of pleomorphic xanthoastrocytoma (PXA) with anaplastic features.
Cheng ZHI, Zhuo-fang HAO, Kai-yong MEI, Xiao-ming OUYANG, Jie-ling WENG, Ling ZHONG, Tian TANG, Li-na LI   +7 more
doaj  

TP53 mutational status is a potential marker for risk stratification in Wilms tumour with diffuse anaplasia.

PLoS ONE, 2014
PurposeThe presence of diffuse anaplasia in Wilms tumours (DAWT) is associated with TP53 mutations and poor outcome. As patients receive intensified treatment, we sought to identify whether TP53 mutational status confers additional prognostic information.
Mariana Maschietto, Richard D Williams, Tasnim Chagtai, Sergey D Popov, Neil J Sebire, Gordan Vujanic, Elizabeth Perlman, James R Anderson, Paul Grundy, Jeffrey S Dome, Kathy Pritchard-Jones   +10 more
doaj   +1 more source

Morphological evaluation of brain oligodendroastrocytomas sensitivity to antiblastic radiation therapy and chemotherapy

Ukrainian Neurosurgical Journal, 2013
Introduction. The results of oligoastrocytomas (OA) comparative morphological analysis before and after antiblastic therapy are given.
Volodymyr Rozumenko, Vera Semenova, Valentyn Klyuchka   +2 more
doaj   +1 more source

The FGF/FGFR System in the Biology and Therapeutic Landscape of Pediatric CNS Tumors

Medicinal Research Reviews, EarlyView.
ABSTRACT Central nervous system (CNS) tumors are the most common solid malignancies in children, comprising a highly heterogeneous group of neoplasms defined by distinct molecular alterations and clinical behaviors. Advances in molecular genetics have underscored the relevance of specific signaling pathways in driving pediatric tumorigenesis, among ...
Serena Filiberti, Camilla Tavani, Elena Somenza, Nicolas Tassone, Antonio d'Amati, Marta Turati, Roberto Ronca   +6 more
wiley   +1 more source

Investigation of rat progenitor neural cells supernatant antitumor action on glioma cells in conditions of culture

Ukrainian Neurosurgical Journal, 2008
The purpose was to investigate rat progenitor neurocells E12–16 supernatant action on the growth activity of glial tumors in conditions of culture.
V. M. Semenova, L. D. Lyubych, N. I. Lisyany, A. Ya. Glavatskiy, L. P. Stayno   +4 more
doaj   +1 more source

Long‐term outcomes of haploidentical hematopoietic stem cell transplantation with antithymocyte globulin–based myeloablative conditioning in pediatric refractory or relapsed non‐Hodgkin lymphoma

Pediatric Investigation, EarlyView.
Single‐center retrospective data showed that ATG‐based myeloablative haploidentical hematopoietic stem cell transplantation provides durable remission and favorable long‐term survival in children with refractory/relapsed non‐Hodgkin lymphoma, achieving high engraftment rates, low relapse incidence, and acceptable toxicity.
Chenguang Jia, Jie Zheng, Meng Yuan, Hongbo He, Yibo Fan, Bin Wang, Guanghua Zhu, Jun Yang, Yanhui Luo, Lixiao Cai, Pan Zhang, Yanlong Duan, Maoquan Qin   +12 more
wiley   +1 more source

Ultra-estrutura dos mastócitos de diferentes tipos histológicos de mastocitoma em cães Mast cell ultrastructure in different types of canine mast cell tumor

Arquivo Brasileiro de Medicina Veterinária e Zootecnia, 2002
Este trabalho teve por objetivo estudar as diferenças ultraestruturais de mastócitos neoplásicos de diferentes tipos histológicos de mastocitoma em cães, usando microscopia eletrônica de transmissão Os resultados mostraram que o núcleo e os grânulos ...
F.A.R. Sueiro, C.R. Daleck, A.C. Alessi
doaj   +1 more source

anaplasia

Citation: 'anaplasia' in the IUPAC Compendium of Chemical Terminology, 5th ed.; International Union of Pure and Applied Chemistry; 2025. Online version 5.0.0, 2025. 10.1351/goldbook.15460 • License: The IUPAC Gold Book is licensed under Creative Commons Attribution-ShareAlike CC BY-SA 4.0 International for individual terms.
openaire   +1 more source